![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, December 10, 2012 11:43:28 AM
I believe you are correct but I also think the place we are at as investors is potentially a very good one.
There are numerous companies and devices in limbo at the FDA for re-classification, or not.
Obviously the FDA is addressing a number of issues at great cost and passage of time. They would not be doing so without a professional desire to receive submissions, listen to input and get it right
The device space BIEL is in was clearly muddled before, so clarity will be a good thing for that space, and hopefully for BIEL.
Having said all that, is it not a good thing to have BIEL alive and in the running for re-classification coming out of the April meeting?
I think it bodes well for the company and the share price.
Bottom line is the products work very well, zero side-effects and they will help people manage pain, drug free. No downside as I see it.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM